Gerdisch et al. |
Mitral Valve |
Adult |
19 |
Mean 10.9 months |
Valves showed good
function and no evidence of calcification |
Yes |
Sundermann et
al. |
Mitral Valve |
Adult |
2 |
34 days and 3 months |
Successful
repair |
Yes |
Zaidi et al. |
Mitral and Aortic Valve |
Pediatric |
9 |
MV: median 64 days AV: median
63 days |
8 MV reoperations for valve dysfunction, 6 patch related MV
re-ops. 3 post AV repair for failure |
No |
Luk et al. |
Mitral Valve |
Adult |
2 |
10 and 18 months |
Delayed postoperative
infection and perforation of MV leaflet |
No |
Kelley
et al. |
Mitral Valve |
Adult |
44 |
12 months |
8 (32%) recurrence
of severe MR, 7 (28%) re-operations for patch failure |
No |
Wallen
et. al |
Tricuspid Valve |
Adult |
1 |
3 months |
Excellent valve
function |
Yes |
Hoffman et. al |
Aortic Valve |
Pediatric |
6 |
119 ‐ 441 days |
Significant valve
insufficiency in 5 patients |
No |
Padalino et al. |
Pulmonary and Aortic Valve |
Pediatric |
22 |
23 months |
Gradual
functional deterioration at midterm |
No |
Mosala
et al. |
Aortic Valve |
Peadiatric |
1 |
4 years |
Valve failure with
severe calcification, fibrosis, and retraction |
No |
Szalanski et al. |
Mitral and Tricuspid Valve |
Adult |
1 |
52 days |
Good early
hemodynamic results |
Yes |
Czub
et al. |
Tricuspid Valve |
Adult |
1 |
6 months |
No tricuspid
regurgitation; no reinfection |
Yes |
Nathan
et al. |
Aortic Valve |
Pediatric |
75 |
5 years |
AVr with CorMatrix
associated with earlier time to reintervention |
No |